H. Kaku et al. / Tetrahedron 66 (2010) 9450e9455
9455
(dddd, J¼1.6, 3.7, 7.2, 11.1 Hz, 1H), 1.98e2.10 (m, 2H), 2.33 (dddd,
J¼1.3, 6.0, 12.7, 13.7 Hz, 1H), 2.41 (dd, J¼8.8, 13.9 Hz, 1H), 2.40e2.47
(m, 1H), 2.50e2.59 (m, 1H), 3.23 (dd, J¼4.9, 13.9 Hz, 1H), 7.13e7.21
4.4.7. (R)-2-Isopentylcyclohexanone: (R)-8. Chiral GLC analysis,
tR¼40.3 (R), 41.4 (S) min (SUPERCO,
-DEX120, 110 ꢃC).
a
20
[a
]
þ14.8 (c 0.997, CHCl3) (46% ee). CDCHCl3
[q]¼þ1323,
D
(m, 3H), 7.24e7.30 (m, 2H); 13C NMR (100 MHz, CDCl3)
d
25.3, 28.2,
D3¼þ0.401 (46% ee). 1H NMR (400 MHz, CDCl3)
d
0.871 (d, J¼6.6 Hz,
33.6, 35.6, 42.4, 52.7, 126.1, 128.5, 129.3, 140.5, 212.8; IR (ATR)
1704.8 (C]O) cmꢀ1; MS (EI) m/z: 188 (Mþ, base peak), 159, 145, 97,
91; HRMS (EI) m/z: (Mþ) calcd for C13H16O, 188.1201; found,
188.1195.
3H), 0.883 (d, J¼6.6 Hz, 3H), 1.10e1.24 (m, 3H), 1.39 (dddd, J¼3.6,
11.2,11.2, 13.2 Hz,1H),1.52 (m,1H), 1.58e1.64 (m, 1H), 1.64e1.72 (m,
1H), 1.72e1.80 (m, 1H), 1.80e1.89 (m, 1H), 1.98e2.06 (m, 1H),
2.07e2.15 (m, 1H), 2.18e2.26 (m, 1H), 2.26e2.33 (m, 1H), 2.39
(dddd, J¼1.4, 4.3, 4.3, 13.3, 1H); 13C NMR (100 MHz, CDCl3)
d 17.3,
4.4.2. (R)-2-(2-Methoxyethyl)cyclohexanone: (R)-318. Chiral GLC
17.5, 19.7, 22.1, 22.9, 23.1, 28.7, 31.3, 36.8, 45.9, 208.6; IR (ATR)
1708.6 (C]O) cmꢀ1; MS (EI) m/z: 168 (Mþ), 145, 126, 111, 98 (base
peak); HRMS (EI) m/z: (Mþ) calcd for C11H20O, 168.1514; found,
168.1517.
analysis, tR¼24.6 (R), 25.3 (S) min (SUPERCO,
a
[q
-DEX120, 100 ꢃC).
]¼þ1880, D3¼þ0.57
[
a]
25 þ1.1 (c 8.68, CHCl3) (68% ee). CDCHCl3
D
(94% ee). 1H NMR (400 MHz, CDCl3)
d 1.45e1.33 (m, 2H), 1.75e1.60
(m, 2H), 1.90e1.81 (m, 1H), 2.10e2.02 (m, 1H), 2.18e2.10 (m, 2H),
2.36e2.27 (m, 1H), 2.44e2.36 (m, 1H), 2.53e2.45 (m, 1H), 3.31 (s,
3H), 3.39 (ddd, J¼5.9, 6.9, 9.4 Hz, 1H), 3.43 (ddd, J¼5.9, 6.5, 9.4 Hz,
4.4.8. 2-Propylcyclohexanone: 9. Chiral GLC analysis, tR¼17.3,
17.6 min (SUPERCO, a
-DEX120, 90 ꢃC).
1H); 13C NMR (100 MHz, CDCl3)
d
25.0, 28.0, 29.3, 34.2, 42.1, 47.1,
1H NMR (400 MHz, CDCl3)
d
0.899 (t, J¼7.2 Hz, 3H), 1.13e1.24 (m,
58.4, 213.0; IR (ATR) 1706.7 (C]O) cmꢀ1; MS (EI) m/z: 156 (Mþ), 98
(base peak); HRMS (EI) m/z: (Mþ) calcd for C9H16O2, 156.1150;
found, 156.1152.
1H), 1.24e1.35 (m, 2H), 1.34e1.44 (m, 1H), 1.59e1.81 (m, 3H),
1.81e1.89 (m, 1H), 1.96e2.06 (m, 1H), 2.06e2.14 (m, 1H), 2.23e2.33
(m, 2H), 2.39 (dddd, J¼1.4, 4.3, 4.4, 13.5 Hz, 1H); 13C NMR (100 MHz,
CDCl3)
d 14.1, 20.2, 24.7, 27.9, 31.4, 33.7, 41.8, 50.4, 213.6; IR (ATR)
4.4.3. (R)-2-Allylcyclohexanone:
was purchased from Aldrich and used without further purification.
(R)-418. (ꢁ)-Allylcyclohexanone
1706.7 (C]O) cmꢀ1; MS (EI) m/z: 140 (Mþ), 111, 98 (base peak);
HRMS (EI) m/z: (Mþ) calcd for C9H16O, 140.1201; found, 140.1203.
Chiral GLC analysis, tR¼24.6 (R), 25.2 (S) min (SUPERCO,
a-
DEX120, 90 ꢃC).
Acknowledgements
25
[
a]
þ8.7 (c 1.08, MeOH) (68% ee). CDCHCl3
[q]¼þ1970,
D
D3¼þ0.60 (78% ee).
This work was supported in part by a Grant-in-Aid for Scientific
Research (C, 19590028) from the Ministry of Education, Culture,
Sports, Science and Technology of Japan. We are also thankful to
MEXT.SENRYAKU, 2008.
4.4.4. (R)-2-(4-Methylbenzyl)cyclohexanone: (R)-5. Chiral HPLC
analysis, tR¼28.0 (R), 37.3 (S) min (DAICEL CHIRALCEL AD, hexane/
isopropanol¼999/1, flow rate 0.5 mL/min, UV254).
24
[
a]
þ36.0 (c 1.00, CHCl3) (78% ee). CDCHCl3
[
q
]¼þ2058,
D
Supplementary data
D3¼þ0.624 (78% ee). 1H NMR (400 MHz, CDCl3)
d
1.34 (dddd, J¼3.5,
11.9, 11.9, 13.3 Hz, 1H), 1.51e1.63 (m, 1H), 1.61e1.74 (m, 1H), 1.82
(dddd, J¼1.6, 3.8, 7.5, 11.2 Hz, 1H), 1.98e2.09 (m, 2H), 2.27e2.36 (m,
1H), 2.31 (s, 3H), 2.37 (dd, J¼9.0, 14.1 Hz, 1H), 2.39e2.47 (m, 1H),
2.48e2.56 (m, 1H), 3.19 (dd, J¼4.7, 13.9 Hz, 1H), 7.04 (d, J¼8.0 Hz,
Supplementary data associated with this article can be found in
References and notes
2H), 7.08 (d, J¼8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3)
d 20.9, 24.9,
27.9, 33.2, 34.9, 42.0, 52.4, 128.8, 128.9, 135.3, 137.1, 212.6; IR (ATR)
1706.7 (C]O) cmꢀ1; MS (EI) m/z: 202 (Mþ), 173, 159, 105 (base
peak), 97; HRMS (EI) m/z: (Mþ) calcd for C14H18O, 202.1358; found,
202.1362.
1. Duhamel, L.; Duhamel, P.; Plaquevent, J.-C. Tetrahedron: Asymmetry 2004, 15,
3653e3691.
2. Eames, J.; Weerasooriya, N. Tetrahedron: Asymmetry 2001, 12, 1e24.
3. Yanagisawa, A.; Yamamoto, H. In Comprehensive Asymmetric Catalysis; Jacobsen,
E. N., Pfalts, A., Yamamoto, H., Eds.; Springer: New York, NY, 1999; Vol. 3,
pp 1295e1306; Yanagisawa, A.; Yamamoto, H. In Comprehensive Asymmetric
Catalysis; Jacobsen, E. N., Pfalts, A., Yamamoto, H., Eds.; Springer: New York, NY,
2004; pp 125e132; Supplement 2.
4.4.5. (R)-2-Benzylcycloheptanone: (R)-619. Chiral HPLC analysis,
tR¼12.0 (R), 16.7 (S) min (DAICEL CHIRALCEL OJ, hexane/iso-
4. Hughes, D. L. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfalts, A.,
Yamamoto, H., Eds.; Springer: New York, NY, 1999; Vol. 3, pp 1273e1294;
Hughes, D. L. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfalts, A.,
Yamamoto, H., Eds.; Springer: New York, NY, 2004; pp 161e169; Supplement 1.
5. Notz, W.; Tanaka, F.; Barbas, C. F. Acc. Chem. Res. 2004, 37, 580e591.
propanol¼9/1, flow rate 0.5 mL/min, UV254).
21
[
a]
þ19.2 (c 1.00, CHCl3) (27% ee). 1H NMR (400 MHz, CDCl3)
D
d
1.26e1.40 (m, 3H), 1.56e1.68 (m, 1H), 1.72e1.90 (m, 4H),
2.42e2.48 (m, 2H), 2.56 (dd, J¼8.4, 13.7 Hz, 1H), 2.77e2.86 (m, 1H),
ꢀ
6. d’Angelo, J.; Desmaele, D.; Dumas, F.; Guingant, A. Tetrahedron: Asymmetry
3.08 (dd, J¼5.9, 13.7 Hz, 1H), 7.13e7.21 (m, 3H), 7.24e7.30 (m, 2H);
1992, 3, 459e505.
13C NMR (100 MHz, CDCl3)
d 24.1, 28.5, 29.2, 30.2, 37.8, 43.1, 53.5,
7. Job, A.; Janeck, C. F.; Bettray, W.; Peters, R.; Enders, D. Tetrahedron 2002, 58,
2253e2329.
125.9, 128.2, 129.0, 139.9, 215.5; IR (ATR) 1697.0 (C]O) cmꢀ1; MS
(EI) m/z: 202 (Mþ, base peak), 159, 145, 91; HRMS (EI) m/z: (Mþ)
calcd for C14H18O, 202.1358; found, 202.1357.
8. Toda, F.; Shinyama, T. J. Chem. Soc., Perkin Trans. 1 1997, 1759e1761.
9. Matsumoto, K.; Okamoto, T.; Otsuka, K. Bull. Chem. Soc. Jpn. 2004, 77,
2051e2056.
10. Sakai, K.; Sakurai, R.; Yuzawa, A.; Hirayama, N. Tetrahedron: Asymmetry 2003,
14, 3713e3718.
11. Tsunoda, T.; Kaku, H.; Nagaku, M.; Okuyama, E. Tetrahedron Lett. 1997, 38,
7759e7760.
12. Kaku, H.; Ozako, S.; Kawamura, S.; Takatsu, S.; Ishii, M.; Tsunoda, T. Heterocycles
2001, 55, 847e850.
13. Seebach, D.; Beck, A. K.; Imwikelried, R.; Roggo, S.; Wonnacott, A. Helv. Chim.
Acta 1987, 70, 954e974.
14. Kaku, H.; Takaoka, S.; Tsunoda, T. Tetrahedron 2002, 58, 3401e3407.
15. Kaku, H.; Okamoto, N.; Nakamaru, A.; Tsunoda, T. Chem. Lett. 2004, 33, 516e517.
16. Kaku, H.; Okamoto, N.; Nishii, T.; Horikawa, M.; Tsunoda, T. Synthesis 2010,
2931e2934.
4.4.6. (R)-2-Prenylcyclohexanone: (R)-7. Chiral GLC analysis,
tR¼18.8 (R), 19.2 (S) min (SUPERCO,
a
-DEX120, 120 ꢃC).
22
[
a]
þ22.7 (c 1.01, CHCl3) (99% ee). CDCHCl3
[q
]¼þ2100,
D
D3¼þ0.636 (99% ee). 1H NMR (400 MHz, CDCl3)
d
1.35 (dddd, J¼3.9,
11.9, 11.9, 13.1 Hz, 1H), 1.58e1.74 (m, 2H), 1.60 (d, J¼0.4 Hz, 3H), 1.69
(d, J¼1.0 Hz, 3H), 1.81e1.89 (m, 1H), 1.96 (ddd, J¼7.4, 8.0, 14.7 Hz,
1H), 2.00e2.08 (m, 1H), 2.08e2.16 (m, 1H), 2.24e2.34 (m, 2H),
2.36e2.46 (m, 2H), 5.08 (m, 1H); 13C NMR (100 MHz, CDCl3)
d 17.7,
17. See Ref. 12.
24.9, 25.7, 27.7, 27.9, 32.3, 41.9, 51.0, 121.9, 132.9, 213.1; IR (ATR)
1708.6 (C]O) cmꢀ1; MS (EI) m/z: 166 (Mþ), 111, 98 (base peak);
HRMS (EI) m/z: (Mþ) calcd for C11H18O, 166.1358; found, 166.1355.
18. Meyers, A. I.; Williams, D. R.; Erickson, G. W.; White, S.; Druelinger, M. J. Am.
Chem. Soc. 1981, 103, 3081e3087.
19. Lu, S.-M.; Bolm, C. Angew. Chem., Int. Ed. 2008, 47, 8920e8923.